Skip to main content
. 2022 Nov 8;13:874028. doi: 10.3389/fphar.2022.874028

FIGURE 3.

FIGURE 3

Overall survival for the study groups (Placebo vs. PMA-ZEO) stratified by I° line treatment and <9 cycles of chemotherapy (CHT).